Radiolabeled products in rat liver and serum after administration of antibody-amide-DTPA-indium-111. 1992

C H Paik, and V K Sood, and N Le, and L Cioloca, and J A Carrasquillo, and J C Reynolds, and R D Neumann, and R C Reba
Radiopharmaceutical Chemistry Section, George Washington University Medical Center, Washington, DC 20037.

Anti-human serum albumin antibody (Ab) was used as a model antibody. Ab was conjugated with DTPA using cyclic DTPA dianhydride reaction and radiolabeled with 111In. The labeled Ab was purified by affinity chromatography. Size exclusion HPLC of this product showed 62% of 111In bound to monomeric Ab and 38% of the activity bound to antibody oligomers with molecular weights ranging from 300,000 to 450,000. The labeled antibody preparation was injected into the tail vein of rats. The radioactive substances in serum and the supernatant from liver homogenates were analyzed for molecular weight and immunoreactivity. Size exclusion HPLC of the serum samples indicated that the monomeric and dimeric Abs disappeared from the serum at a similar rate over a 48 h period. In addition, a new radioactive substance with an estimated molecular weight of 35,000 appeared in the serum. The immunoreactive fraction of the circulating 111In substances decreased slowly, somewhat proportional to the appearance of the metabolite. On the other hand, the immunoreactivity of the 111In substances in the supernatant from the liver homogenate decreased rapidly and no appreciable immunoreactivity was observed after 48 h. The labeled antibody was catabolized very rapidly in the liver and the major activity in the supernatant was associated with a small molecular weight metabolite which had a HPLC retention time identical to that of DTPA-111In. The second metabolite had an estimated molecular weight of 35,000. No radioactivity was associated with transferrin.

UI MeSH Term Description Entries
D007205 Indium Radioisotopes Unstable isotopes of indium that decay or disintegrate emitting radiation. In atoms with atomic weights 106-112, 113m, 114, and 116-124 are radioactive indium isotopes. Radioisotopes, Indium
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007553 Isotope Labeling Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms. Isotope Labeling, Stable,Isotope-Coded Affinity Tagging,Isotopically-Coded Affinity Tagging,Affinity Tagging, Isotope-Coded,Affinity Tagging, Isotopically-Coded,Isotope Coded Affinity Tagging,Labeling, Isotope,Labeling, Stable Isotope,Stable Isotope Labeling,Tagging, Isotope-Coded Affinity,Tagging, Isotopically-Coded Affinity
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D002846 Chromatography, Affinity A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Bioaffinity,Immunochromatography,Affinity Chromatography,Bioaffinity Chromatography
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004369 Pentetic Acid An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium. DTPA,Diethylenetriamine Pentaacetic Acid,Pentetates,Penthanil,Ca-DTPA,CaDTPA,CaNa-DTPA,Calcium Trisodium Pentetate,DETAPAC,Indium-DTPA,Mn-Dtpa,Pentacin,Pentacine,Pentaind,Pentetate Calcium Trisodium,Pentetate Zinc Trisodium,Sn-DTPA,Zinc-DTPA,Indium DTPA,Pentaacetic Acid, Diethylenetriamine,Pentetate, Calcium Trisodium,Zinc DTPA
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D012709 Serum Albumin A major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules. Plasma Albumin,Albumin, Serum

Related Publications

C H Paik, and V K Sood, and N Le, and L Cioloca, and J A Carrasquillo, and J C Reynolds, and R D Neumann, and R C Reba
May 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
C H Paik, and V K Sood, and N Le, and L Cioloca, and J A Carrasquillo, and J C Reynolds, and R D Neumann, and R C Reba
June 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
C H Paik, and V K Sood, and N Le, and L Cioloca, and J A Carrasquillo, and J C Reynolds, and R D Neumann, and R C Reba
December 1997, Thrombosis research,
C H Paik, and V K Sood, and N Le, and L Cioloca, and J A Carrasquillo, and J C Reynolds, and R D Neumann, and R C Reba
January 1997, Langenbecks Archiv fur Chirurgie,
C H Paik, and V K Sood, and N Le, and L Cioloca, and J A Carrasquillo, and J C Reynolds, and R D Neumann, and R C Reba
January 1998, Thrombosis research,
C H Paik, and V K Sood, and N Le, and L Cioloca, and J A Carrasquillo, and J C Reynolds, and R D Neumann, and R C Reba
October 1986, Investigative radiology,
C H Paik, and V K Sood, and N Le, and L Cioloca, and J A Carrasquillo, and J C Reynolds, and R D Neumann, and R C Reba
June 1998, Urology,
C H Paik, and V K Sood, and N Le, and L Cioloca, and J A Carrasquillo, and J C Reynolds, and R D Neumann, and R C Reba
April 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
C H Paik, and V K Sood, and N Le, and L Cioloca, and J A Carrasquillo, and J C Reynolds, and R D Neumann, and R C Reba
January 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
C H Paik, and V K Sood, and N Le, and L Cioloca, and J A Carrasquillo, and J C Reynolds, and R D Neumann, and R C Reba
August 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!